Search Results - "Keyter, Andrea"
-
1
Can Standardisation of the Public Assessment Report Improve Benefit-Risk Communication?
Published in Frontiers in pharmacology (17-06-2020)“…National regulatory authorities (NRAs) make the decision to register a medicine based on an assessment of its benefits and risks and publicly available…”
Get full text
Journal Article -
2
South African Regulatory Authority: The Impact of Reliance on the Review Process Leading to Improved Patient Access
Published in Frontiers in pharmacology (23-07-2021)“…Background: The aims of this study were to compare the overall regulatory review timelines achieved by the South African Health Products Regulatory Authority…”
Get full text
Journal Article -
3
The South African Medicines Control Council: Comparison of Its Registration Process With Australia, Canada, Singapore, and Switzerland
Published in Frontiers in pharmacology (14-03-2019)“…Comparisons between regulatory authorities of similar size and regulatory characteristics facilitate value-added benchmarking and provide insight into…”
Get full text
Journal Article -
4
The South African Regulatory System: Past, Present, and Future
Published in Frontiers in pharmacology (04-12-2018)“…The drive for improved regulatory systems and the establishment of a more effective regulatory framework in South Africa has been evident for the past two…”
Get full text
Journal Article -
5
A Proposed Regulatory Review Model to Support the South African Health Products Regulatory Authority to Become a More Efficient and Effective Agency
Published in International journal of health policy and management (01-06-2022)“…National regulatory agencies of various sizes and maturity levels, including the South African Health Products Regulatory Authority (SAHPRA), have had to…”
Get full text
Journal Article -
6
The Regulatory Review Process in South Africa: Challenges and Opportunities for a New Improved System
Published in Therapeutic innovation & regulatory science (01-07-2018)“…The aims of this study were to assess the regulatory review process in South Africa from 2015 to 2017, identify the key milestones and timelines; evaluate the…”
Get more information
Journal Article -
7
Evaluation of the Performance of the South Africa Regulatory Agency: Recommendations for Improved Patients' Access to Medicines
Published in Therapeutic innovation & regulatory science (01-07-2020)“…Timely access to new medicines may be addressed through strengthening of registration efficiencies and timelines by establishing and refining value-added…”
Get more information
Journal Article